Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Beckman Coulter Access HIV Ag/Ab Combo Assay as an Aid in the Diagnosis of HIV-1 and/or HIV-2 Infection: EU Clinical Trial Protocol

NCT04971343 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT04971343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04971343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Beckman Coulter Access HIV Ag/Ab Combo Assay as an Aid in the Diagnosis of HIV-1 and/or HIV-2 Infection: EU Clinical Trial Protocol
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
December 4, 2019
Completion date
September 23, 2022
Enrollment
8,650 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv i infection, hiv-2 infection